Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
Your Article Summary
Breast Hamartomas in Adolescent Females
The Breast Journal, 09/17/09
Goldstein AM et al. – Breast hamartomas are rare in the adolescent population. The clinical and radiographic features are similar to the more common fibroadenoma, but the pathologic findings are diagnostic. Recurrence can occur if excision is incomplete. Increased recognition and accurate diagnosis will improve understanding of the natural history of these lesions.
Related Articles
Large plaque-type blue naevus with subcutaneous cellular nodules
Clinical and Experimental Dermatology, 10/16/09
Relevance Score: 63%
Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers
Journal of Clinical Oncology, 10/29/09
Relevance Score: 49%
New-Onset Breast Tenderness After Initiation of Estrogen Plus Progestin Therapy and Breast Cancer Risk
Archives of Internal Medicine, 10/13/09
Relevance Score: 49%
Assessing the usefulness of a novel MRI-based breast density estimation algorithm in a cohort of women at high genetic risk of breast cancer: The UK MARIBS study
Breast Cancer Research, 11/17/09
Relevance Score: 48%
Breast-feeding the last born child and risk of ovarian cancer
Cancer Causes and Control, 11/16/09
Relevance Score: 48%
Today in Breast...keeping you current
Receive free subspecialty "5-minute updates" via email
A novel intralymphatic nanocarrier delivery system for cisplatin therapy in breast cancer with improved tumor efficacy and lower systemic toxicity in vivo
The American Journal of Surgery, 12/11/09
Nipple adenoma in infancy
Journal of Pediatric Surgery, 12/11/09
Private insurance is the strongest predictor of women receiving breast conservation surgery for breast cancer
The American Journal of Surgery, 12/11/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


